PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in Canada
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1166
https://www.valueinhealthjournal.com/article/S1098-3015(11)02728-8/fulltext
Title :
PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02728-8&doi=10.1016/j.jval.2011.08.1166
First page :
A445
Section Title :
Cancer
Open access? :
No
Section Order :
1123